ADAR and hnRNPC deficiency synergize in activating endogenous dsRNA-induced type I IFN responses
Author(s) -
AnnaMaria Herzner,
Zia Khan,
Eric L. Van Nostrand,
Sara M. Chan,
Trinna Cuellar,
Ronald Chen,
Ximo Pechuan-Jorge,
László G. Kömüves,
Margaret Solon,
Zora Modrušan,
Benjamin Haley,
G Yeo,
Timothy W. Behrens,
Matthew L. Albert
Publication year - 2021
Publication title -
the journal of experimental medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.483
H-Index - 448
eISSN - 1540-9538
pISSN - 0022-1007
DOI - 10.1084/jem.20201833
Subject(s) - adar , mda5 , rna silencing , rna editing , biology , alu element , rna , endogeny , rna binding protein , transcriptome , microbiology and biotechnology , genetics , rna interference , biochemistry , gene expression , gene , genome , human genome
Cytosolic double-stranded RNA (dsRNA) initiates type I IFN responses. Endogenous retroelements, notably Alu elements, constitute a source of dsRNA. Adenosine-to-inosine (A-to-I) editing by ADAR induces mismatches in dsRNA and prevents recognition by MDA5 and autoinflammation. To identify additional endogenous dsRNA checkpoints, we conducted a candidate screen in THP-1 monocytes and found that hnRNPC and ADAR deficiency resulted in synergistic induction of MDA5-dependent IFN responses. RNA-seq analysis demonstrated dysregulation of Alu-containing introns in hnRNPC-deficient cells via utilization of unmasked cryptic splice sites, including introns containing ADAR-dependent A-to-I editing clusters. These putative MDA5 ligands showed reduced editing in the absence of ADAR, providing a plausible mechanism for the combined effects of hnRNPC and ADAR. This study contributes to our understanding of the control of repetitive element-induced autoinflammation and suggests that patients with hnRNPC-mutated tumors might maximally benefit from ADAR inhibition-based immunotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom